The complexity and multifactorial etiology of Alzheimer’s disease (AD) pose unique challenges for studying its pathogenesis and developing therapies. Efforts to target AD-related pathways have shown promise in animal studies, only to fail in human trials1,2. There is a pressing need to identify novel mechanisms and therapeutic targets for AD using human model systems, such as human neurons.
